(2020). Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection by Promoting NFκB Transactivation through NIK/IKK in Human Glioma Cells. PLoS One.
استشهاد بنمط شيكاغو"Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection By Promoting NFκB Transactivation Through NIK/IKK in Human Glioma Cells." PLoS One 2020.
MLA استشهاد"Retraction: DMA, a Bisbenzimidazole, Offers Radioprotection By Promoting NFκB Transactivation Through NIK/IKK in Human Glioma Cells." PLoS One 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.